Activated natural killer (NK) cells mediate graft-versus-tumor (GVT) effects but inhibit graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation.

被引：0
|
作者：
Murphy, WJ
Tian, Z
Asai, O
Hornung, R
Longo, DL
机构：
[1] NCI,FREDERICK CANC RES & DEV CTR,DES,LAB LEUKOCYTE BIOL,FREDERICK,MD 21701
[2] NCI,FREDERICK CANC RES & DEV CTR,SAIC,BCDP,FREDERICK,MD 21701
[3] NIA,BALTIMORE,MD 21224
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1996年 / 44卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A232 / A232
页数：1
相关论文
共 50 条
  • [1] Activated natural killer (NK) cells mediate graft-versus-tumor (GVT) effects but inhibit graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT).
    Murphy, WJ
    Asai, O
    Tian, Z
    Hornung, R
    Longo, DL
    FASEB JOURNAL, 1996, 10 (06): : 2509 - 2509
  • [2] Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation
    Asai, O
    Longo, DL
    Tian, ZG
    Hornung, RL
    Taub, DD
    Ruscetti, FW
    Murphy, WJ
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (09): : 1835 - 1842
  • [3] The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation
    Murphy, WJ
    Longo, DL
    IMMUNOLOGICAL REVIEWS, 1997, 157 : 167 - 176
  • [4] Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
    Czech, Marie
    Zeiser, Robert
    Toubai, Tomomi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
    Storb, Rainer
    Gyurkocza, Boglarka
    Storer, Barry E.
    Sorror, Mohamed L.
    Blume, Karl
    Niederwieser, Dietger
    Chauncey, Thomas R.
    Pulsipher, Michael A.
    Petersen, Finn B.
    Sahebi, Firoozeh
    Agura, Edward D.
    Hari, Parameswaran
    Bruno, Benedetto
    McSweeney, Peter A.
    Maris, Michael B.
    Maziarz, Richard T.
    Langston, Amelia A.
    Bethge, Wolfgang
    Vindelov, Lars
    Franke, Georg-Nikolaus
    Laport, Ginna G.
    Yeager, Andrew M.
    Huebel, Kai
    Deeg, H. Joachim
    Georges, George E.
    Flowers, Mary E. D.
    Martin, Paul J.
    Mielcarek, Marco
    Woolfrey, Ann E.
    Maloney, David G.
    Sandmaier, Brenda M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) : 1530 - 1538
  • [6] Graft-versus-tumor (GvT) effects in the absence of alloantigens on tumor cells crucially depend on graft-versus-host disease (GvHD) intensity.
    Albring, JC
    Stelljes, M
    Berdel, WE
    Kienast, J
    BLOOD, 2005, 106 (11) : 379A - 379A
  • [7] Graft-versus-host disease (GVHD) after nonmyeloablative transplantation.
    Nelson, Robert
    Robertson, Michael
    Schwartz, Jennifer
    Billings, Steven
    Abonour, Rafat
    CLINICAL IMMUNOLOGY, 2006, 119 : S162 - S162
  • [8] The Triterpenoid CDDO-Me Delays Murine Acute Graft-versus-Host Disease with the Preservation of Graft-versus-Tumor Effects after Allogeneic Bone Marrow Transplantation
    Li, Minghui
    Sun, Kai
    Redelman, Doug
    Welniak, Lisbeth A.
    Murphy, William J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) : 739 - 750
  • [9] Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation
    Saad, Ali G.
    Alyea, Edwin P., III
    Wen, Patrick Y.
    DeGirolami, Umberto
    Kesari, Santosh
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) : E147 - E149
  • [10] IFN-γ Receptor-Deficient Donor T Cells Mediate Protection from Graft-versus-Host Disease and Preserve Graft-versus-Tumor Responses after Allogeneic Bone Marrow Transplantation
    Sun, Kai
    Hsiao, Hui-Hua
    Li, Minghui
    Ames, Erik
    Bouchlaka, Myriam
    Welniak, Lisbeth A.
    Hagino, Takeshi
    Jagdeo, Jared
    Pai, Chien-Chun
    Chen, Mingyi
    Blazar, Bruce R.
    Abedi, Mehrdad
    Murphy, William J.
    JOURNAL OF IMMUNOLOGY, 2012, 189 (04): : 2033 - 2042
12345